Aqueous humour penetration of moxifloxocin and gatifloxacin eye drops in different dosing regimens before phacoemulsification surgery

British Journal of Ophthalmology

Volumn 95, Issue 9, 2011, Pages 1272-1275

  Güngör, Sirel Gür ^a,b   Akova, Yonca Aydin ^a   Bozkurt, Atila ^c   Yaşar, Ümit ^c   Babaoǧlu, Melih Ö ^c   Çetinkaya, Altuǧ ^a   Çolak, Meriç ^a  

^a BASKENT UNIVERSITY   (Turkey)

^b Cankiri State Hospital   (Turkey)

^c HACETTEPE UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

DICLOFENAC; EYE DROPS; GATIFLOXACIN; MOXIFLOXACIN; PHENYLEPHRINE; TROPICAMIDE;

AGED; ANTERIOR EYE CHAMBER; AQUEOUS HUMOR; ARTICLE; ASPIRATION; CONTROLLED STUDY; DOSAGE SCHEDULE COMPARISON; DRUG BLOOD LEVEL; DRUG DOSE REGIMEN; DRUG PENETRATION; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; PHACOEMULSIFICATION; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL;

AGED; ANTI-INFECTIVE AGENTS; AQUEOUS HUMOR; AZA COMPOUNDS; CATARACT; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOPHTHALMITIS; FEMALE; FLUOROQUINOLONES; HUMANS; MALE; OPHTHALMIC SOLUTIONS; PHACOEMULSIFICATION; PREOPERATIVE CARE; PROSPECTIVE STUDIES; QUINOLINES; SURGICAL WOUND INFECTION; TREATMENT OUTCOME;

EID: 80052115980     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjo.2010.179762     Document Type: Article

References (12)

1. Ong-Tone L. Aqueous humor penetration of gatifloxacin and moxifloxacin eyedrops given in different concentrations in a wick before cataract surgery. J Cataract Refract Surg 2008;34:819-22. (Pubitemid 351626964)
2. Han DP, Wisniewski SR, Wilson LA, et al. Spectrum and susceptibilities of microbiologic isolates in the Endophthalmitis Vitrectomy Study. Am J Ophthalmol 1996;122:1-17. (Pubitemid 26230889)
3. Katz HR, Masket S, Lane SS, et al. Absorption of topical moxifloxacin ophthalmic solution into human aqueous humor. Cornea 2005;24:955-8. (Pubitemid 41688529)
4. Mather R, Karenchak LM, Romanowski EG, et al. Fourth generation fluoroquinolones: New weapons in the arsenal of ophthalmic antibiotics. Am J Ophthalmol 2002;133:463-6. (Pubitemid 34258055)
5. Kowalski RP, Dhaliwal DK, Karenchak LM, et al. Gatifloxacin and moxifloxacin: An in vitro susceptibility comparison to levofloxacin, ciprofloxacin, and ofloxacin using bacterial keratitis isolates. Am J Ophthalmol 2003;136:500-5. (Pubitemid 37101247)
6. Solomon R, Donnenfeld ED, Perry HD, et al. Penetration of topically applied gatifloxacin 0.3%, moxifloxacin 0.5%, and ciprofloxacin 0.3% into the aqueous humor. Ophthalmology 2005;112:466-9. (Pubitemid 40312502)
7. Kim DH, Stark WJ, O'Brien TP, et al. Aqueous penetration and biological activity of moxifloxacin 0.5% ophthalmic solution and gatifloxacin 0.3% solution in cataract surgery patients. Ophthalmology 2005;112:1992-6. (Pubitemid 41551929)
8. McCulley JP, Caudle D, Aranowicz JD, et al. Fourth generation fluoroquinolone penetration into the aqueous humor in humans. Ophthalmology 2006;14:955-9. (Pubitemid 43795230)
9. Vasavada AR, Gajjar D, Raj SM, et al. Comparison of 2 moxifloxacin regimens for preoperative prophylaxis: Prospective randomized triple-masked trial Part 1: Aqueous concentration of moxifloxacin. J Cataract Refract Surg 2008;34:1379-82. (Pubitemid 352004125)
10. Schentag JJ. Pharmacokinetic and pharmacodynamic predictors of antimicrobial efficacy: Moxifloxacin and Streptococcus pneumoniae. J Chemother 2002;14:13-21. (Pubitemid 34297845)
11. Metzler K, Hansen GM, Hedlin P, et al. Comparison of minimal inhibitory and mutant prevention drug concentrations of 4 fluoroquinolones against clinical isolates of methicillin-susceptible and -resistant Staphylococcus aureus. Int J Antimicrob Agents 2004;24:161-7. (Pubitemid 38993695)
12. Blondeau JM, Zhao X, Hansen G, et al. Mutant prevention concentrations of fluoroquinolones for clinical isolates of Streptococcus pneumoniae. Antimicrob Agents Chemother 2001;45:433-8. (Pubitemid 32105277)